- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ICD-11 to Roll Out in 2017
The revision process for ICD-11 is currently underway and the final version will be released in 2017, according to a fact sheet from the World Health Organization.
The revision process for ICD-11 is currently underway and the final version will be released in 2017, according to a fact sheet from the World Health Organization.
While no official announcement has been made, the 2017 launch date is two years later than had been anticipated — an older version of the WHO fact sheet lists a 2015 roll out for ICD-11.
Some industry stakeholders had advocated the U.S. healthcare industry skip over ICD-10 and begin ICD-11 to keep on pace with the rest of the world. The American Medical Association and others have rejected this idea, claiming jumping to ICD-11 would bring even more disruptions to the industry.
Read more here: http://bit.ly/LXkiHR
Source: Becker's Hospital Review
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
What We’re Reading: Rising Flu Cases; RSV Drug Shortage; Forever Chemical Restrictions
November 20th 2023Health officials said that at least 7 states reported high levels of illness, with cases also rising in other parts of the country; a group of Senate Democrats demanded answers about the shortage of nirsevimab, a new respiratory syncytial virus (RSV) drug; Pentagon officials told Congress that eliminating per- and polyfluorinated substances would undermine military readiness.
Read More
